Journal of International Oncology››2012,Vol. 39››Issue (5): 337-340.

Previous ArticlesNext Articles

Regulation of cyclin E and cancers

GUO Cui-ping, ZHANG Guo-jun

  1. Breast Cancer, Affiliated Cancer Hospital of Shantou University Medical College, Cancer Reasearch Center of Shantou University Medical College, Shantou 515041, China
  • Online:2012-05-08Published:2012-05-02
  • Contact:ZHANG Guo-jun, E-mail: guoj_zhang@yahoo.com E-mail:guoj_zhang@yahoo.com

Abstract:Cyclin E is expressed starting from the middle G1 phase of the cell cycle, and is accumulated in the G1/S boundry. Cyclin E binds to and activates the cyclindependent kinase CDK2. Cyclin E-CDK2 complex initiates a cascade of events that leads to DNA replication by phosphorylating its substrates, such as Rb, CDC6, NPAT and P107, etc. Additionally, cyclin E plays an important role in the regulation of genomic stability, spindleorganizing structure and centrosome cycle. Cyclin E expression is transactivated by members of the transcription factor E2F family and degrades via the ubiquitinproteasome pathway. At the same time, it is also negatively regulated by the CIP/KIP proteins. Cyclin E highly expressed in the initiation and progression of different human cancers, such as breast cancers, lung cancers, leukemia, lymphomas and others.

Key words:Cyclin E,Cell cycle regulation,Cyclins,Neoplasms